These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 2870480)
21. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Brunello N; Masotto C; Steardo L; Markstein R; Racagni G Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893 [TBL] [Abstract][Full Text] [Related]
22. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls. Miller AL; Maas JW; Contreras S; Seleshi E; True JE; Bowden C; Castiglioni J Biol Psychiatry; 1993 Aug; 34(3):178-87. PubMed ID: 8104509 [TBL] [Abstract][Full Text] [Related]
23. Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function. Wolkin A; Duncan E; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J J Neural Transm Gen Sect; 1994; 95(1):49-61. PubMed ID: 7857586 [TBL] [Abstract][Full Text] [Related]
25. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs. List SJ; Cleghorn JM Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522 [TBL] [Abstract][Full Text] [Related]
26. Dopamine, the prefrontal cortex and schizophrenia. Knable MB; Weinberger DR J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376 [TBL] [Abstract][Full Text] [Related]
28. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics. Harris PQ; Brown SJ; Friedman MJ; Bacopoulos NG Biol Psychiatry; 1984 Jun; 19(6):849-60. PubMed ID: 6146355 [TBL] [Abstract][Full Text] [Related]
29. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. Masana M; Bortolozzi A; Artigas F Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825 [TBL] [Abstract][Full Text] [Related]
30. Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat. Kendler KS; Davis KL Psychiatry Res; 1984 Sep; 13(1):51-8. PubMed ID: 6151204 [TBL] [Abstract][Full Text] [Related]
31. The concept of supersensitivity psychosis. Kirkpatrick B; Alphs L; Buchanan RW J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269 [TBL] [Abstract][Full Text] [Related]
32. The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. Grace AA J Neural Transm Suppl; 1992; 36():91-131. PubMed ID: 1356143 [TBL] [Abstract][Full Text] [Related]
33. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics. Kendler KS; Bracha HS; Davis KL Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428 [TBL] [Abstract][Full Text] [Related]
34. The dopamine systems in the brain, functional classification of different dopamine receptors. Ljungberg T Acta Psychiatr Belg; 1987; 87(5):523-34. PubMed ID: 2897758 [TBL] [Abstract][Full Text] [Related]
35. The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs? Crow TJ; Deakin JF; Longden A Psychol Med; 1977 May; 7(2):213-21. PubMed ID: 560024 [TBL] [Abstract][Full Text] [Related]
38. Problems in classification of schizophrenics as neuroleptic responders and nonresponders. Csernansky JG; Kaplan J; Hollister LE J Nerv Ment Dis; 1985 Jun; 173(6):325-31. PubMed ID: 2860202 [TBL] [Abstract][Full Text] [Related]
39. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Meltzer HY; Huang M Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033 [TBL] [Abstract][Full Text] [Related]
40. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics. Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]